In line with this hypothesis, Tox-deficient CD8 T cells exhibited reduced cytokine production, killing capacity and tumor persistence despite having diminished expression of inhibitory surface molecules (PD-1, LAG3) (4). The gene discussed is CD8A; the disease is neoplasm.